NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle cell disease.

May 5, 2024 - 00:00

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle cell disease.

Read the original article

Tags:

Previous Article

ESCMID 2024: Advances in drug resistance testing

BridgeBio Oncology Therapeutics launches with $200m funding

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Atypical Teratoid Rhabdoid Tumor drugs in development, ...

Aug 31, 2024

STAT+: With savvy bets, a dynamic duo makes Eli Lilly one of pharma’s biggest success stories

STAT+: With savvy bets, a dynamic duo makes Eli Lilly o...

Jul 6, 2023

STAT+: From drug shortages to high prices, U.S. system’s shortcomings have deep roots

STAT+: From drug shortages to high prices, U.S. system’...

Aug 15, 2023